Contact Us Menu

Our Leadership

Close

Sujay Jadhav, MBA

Chief Executive Officer

Sujay Jadhav is the Chief Executive Officer at Verana Health where he is helping to accelerate the company’s growth and sustainability by advancing clinical trial capabilities, data-as-a-service offerings, medical society partnerships, and data enrichment.

Sujay joins Verana Health with more than 20 years of experience as a seasoned executive, entrepreneur, and global business leader. Most recently, Sujay was the Global Vice President, Health Sciences Business Unit at Oracle, where he ran the organization’s entire product and engineering teams. Before Oracle, Sujay was the CEO of cloud-based clinical research platform goBalto, where he oversaw the acquisition of the company by Oracle. Sujay is also a former executive for the life sciences technology company Model N, where he helped to oversee its transition to a public company.

Sujay holds an MBA from Harvard University and a bachelor’s degree in electronic engineering from the University of South Australia.

Sujay Jadhav, MBA on LinkedIn
Sujay Jadhav, <span>MBA</span>

Why Verana?

“We are at an inflection point in digital health. We now have the opportunity to transform patient care and cure by extracting quality insights from unfiltered, real-world healthcare data. Verana Health is poised to affect real change by defining and delivering the highest standards of data integrity to power healthcare."

Marc Berger, JD, MBA

Chief Operations Officer

Marc Berger is Chief Operations Officer at Verana Health. He was previously Senior Vice President at Verana Health and a member of the core leadership team responsible for setting Verana Health’s corporate strategy. He served as the company’s General Counsel and Privacy Officer and was responsible for the company’s legal functions, including corporate, privacy, commercial contracting, health law, and intellectual property activities. As Senior Vice President, he also oversaw Verana Health’s Security & Compliance and People & Culture teams.

Prior to joining Verana Health, Marc was General Counsel at Flatiron Health, where he was a member of the four-person team that negotiated the $2.1B acquisition by Roche. Marc has also served as Vice President and Assistant General Counsel at Medidata Solutions, where he had global responsibility for negotiating agreements with life science companies and partners for Medidata’s clinical trial technology and service offerings.

Marc received his JD and MBA from the University of Miami School of Law, and his BS in Management and International Business from Penn State University.

Marc Berger, JD, MBA on LinkedIn
Marc Berger, <span>JD, MBA</span>

Why Verana?

I love working at mission-driven companies. Verana’s deep commitment to improving patient care and accelerating scientific research with clinical data is something the entire organization is behind.

Marie-Eve Piche, MBA, MS

Chief Financial Officer

Marie-Eve Piche, Verana Health’s Chief Financial Officer, has nearly two decades of financial management experience in public and fast-growing private companies. Marie-Eve was previously the CFO of Pymetrics and built the financial strategy and capabilities that enabled a successful Series B fundraising. She also served as Vice President of Financial Planning and Analysis at AppNexus, where she helped grow revenue by more than six times during her tenure and was on the team that drove the $1.6B acquisition by AT&T. She began her career at General Electric, holding key financial roles at NBC Sports and Telemundo.

Marie-Eve received her dual MBA from Columbia University and London Business School. She also holds a Master’s in economics from McGill University and a B.Com. from H.E.C. Montreal.

Marie-Eve Piche, MBA, MS on LinkedIn
Marie-Eve Piche, <span>MBA, MS</span>

Why Verana?

Verana Health is a company that is doing ground-breaking work with technology and data, and is being built by a team that works tirelessly to deliver against its commitment to patients. I'm thrilled to contribute to the impact I know this company will make.

Lawrence Whittle

Chief Commercial Officer

Lawrence Whittle is Chief Commercial Officer based in California. Lawrence is responsible for driving the market positioning and customer success at Verana Health. His remit spans a multitude of stakeholders, leading medical society engagement, healthcare provider experience, and life sciences partnerships, as well as the marketing and quantitative sciences functions to elevate awareness and value across the care continuum.

Lawrence has 25+ years experience as a senior executive within technologies companies spanning different industries, including Data Analytics and Life Sciences. His deep expertise in commercialization has covered elevating company positioning, driving sustainable customer value through deep in-market partnerships, and nurturing strong collaborations across all key functions of the business. His experience in early- and mid-stage companies has resulted in two IPOs and two M&A transactions.

Lawrence was born in London and is a true global citizen, having worked across many countries. He has been based in California since 2008 where he lives with his wife and three children.

Lawrence Whittle on LinkedIn
Lawrence Whittle

Why Verana?

I have been fortunate to work at several amazing companies that have used advanced technology to enhance business outcomes, but the Verana Health mission is truly unique and inspirational. It’s exciting to have the opportunity to utilize a significant and highly differentiated data set to drive major improvements to the speed and efficacy of healthcare across multiple therapeutic areas. I am honored to be part of this motivational Verana Health mission to help improve healthcare outcomes.

Chris Reiling, BA

Chief Revenue Officer

Chris Reiling is the Chief Revenue Officer for Verana Health. Chris leads the sales team and is responsible for the company’s revenue generation strategy and execution as well as its go-to-market approach.

Chris is a sales and account management executive with more than 15 years of experience scaling revenue and growth by optimizing sales processes, business development, strategic alliances, market positioning, and commercialization—primarily focused on healthcare data and technology. Prior to joining Verana Health, Chris held varying sales leadership roles at IQVIA across its life sciences and MedTech business, with his most recent responsibilities leading the U.S. Real World Data & Technology sales team.

Chris holds a BA in Economics from The University of Connecticut.

Chris Reiling, BA on LinkedIn
Chris Reiling, <span>BA</span>

Why Verana?

I have always been fascinated by the power of what data can bring to decision making, specifically in healthcare and drug development. Verana Health’s mission to leverage deep real-world data in conjunction with scientific rigor and technology excites me. It’s an honor to be part of this journey and support our efforts in unlocking the promise of reducing clinical development costs, so life enhancing therapeutics can get to patients faster.

Shrujal Baxi, MD, MPH

Senior Vice President of Clinical and Scientific Solutions

Shrujal Baxi, MD, MPH, serves on the Medical team as the Senior Vice President of Clinical and Scientific Solutions at Verana Health, and will advance the development and use of real-world evidence to address challenges in patient outcomes, healthcare delivery and drug development. Prior to joining Verana Health, Dr. Baxi was the Head of Clinical Science at Flatiron Health and led the development and use of EHR-derived real-world evidence in oncology. She also had an academic career as a medical oncologist and Health Outcomes/Health Services Researcher at Memorial Sloan Kettering Cancer Center. Dr. Baxi completed her Bachelor of Arts degree, Master of Public Health degree and Doctor of Medicine degree at the University of Illinois at Chicago.

Shrujal Baxi, MD, MPH on LinkedIn
Shrujal Baxi, <span>MD, MPH</span>

Why Verana?

I joined Verana because its a company that is trying to solve the hard problem of transforming the information buried in electronic health records into analyzable data using technological solutions which can be scaled and the learnings transferred across disease settings to create dynamic data which can ultimately answer a broad range of questions and challenges facing patients, providers, drug developers, payers and others in the health care sector. I really look forward to being part of the Verana Health team as we start to close the chasm between the retrospective and prospective data moving forward.

Kirk Fjeldheim

Senior Vice President, Engineering and Security

Kirk Fjeldheim is Senior Vice President of Engineering and Security, where he is responsible for Verana Health’s data, infrastructure and corporate protection strategies, which include identifying, developing, implementing, and maintaining processes across product and corporate systems. Kirk also manages corporate IT and Compliance. Kirk Fjeldheim brings several decades of experience at high-growth technology companies to Verana Health. Prior to joining Verana Health, Kirk was Chief Information Security Officer at Syapse, Inc. and Chief Information Officer at SugarCRM. As Vice President of IT and Security at Rally Health, he led Security, compliance and IT for more than 1,400 employees and developed and implemented HIPAA compliance and risk management efforts for a customer application reaching 38 million users. He has also held senior IT positions at Zynga, Xsigo Systems, Openwave Systems, and Siebel Systems.

Kirk Fjeldheim on LinkedIn
Kirk Fjeldheim

Why Verana?

Insights from health data are a critical component of improving the lives of people all over the world. I am thrilled to work at a company where technologists and data scientists are working together to improve quality of care and to advance medical research.

Ann Watson

Senior Vice President,
People & Culture

Ann Watson is Verana Health’s Senior Vice President of People and Culture, bringing a passion for building teams to Verana Health’s next phase of growth. The People & Culture team is responsible for all phases of the employee lifecycle: from finding great people to supporting their development all the way through to the alumni phase. Ann has over twenty years of experience in Human Resources and Talent Acquisition, primarily with small and mid-sized technology organizations. Ann was previously the Chief People Officer at MasterClass, at Varo Bank, and ran the Employee Experiences organization at Fandom. She specializes in growing teams from 50 to 500+, doubling the team multiple years in a row, building infrastructure to scale through the early start-up stage to mid-size maturity and beyond.

Ann has a BA from Santa Clara University and is a member of PeopleTechPartners, an organization devoted to accelerating solutions that drive the future of work.

Ann Watson on LinkedIn
Ann Watson

Why Verana?

In addition to being drawn to the incredible mission of improving patient outcomes, the people are why I chose Verana. It is an incredible privilege to work with this team and I’m very appreciative of the overall lack of jerks. Verana is doing great work with great people!

Sonja Wustrack, MPH

Senior Vice President,
Commercial Operations

Sonja Wustrack is Senior Vice President, Commercial Operations at Verana Health, where she brings over 20 years of health research experience, including academic research, public health surveillance, clinical trial technology, and clinical research. Within the biotechnology and pharmaceutical space, she has held positions in delivery, operations management, sales enablement leadership and account management. Most recently at IQVIA, Sonja focused on enhancing customer engagement and demonstrating improved value through for pharma, payors, providers and patients by leveraging real-world data and analytics to innovate clinical trial design and accelerate execution.

Sonja holds an MPH in Epidemiology from the Tulane School of Public Health, and a Bachelor’s degree in biology from Vassar College.

Sonja Wustrack, MPH on LinkedIn
Sonja Wustrack, <span>MPH</span>

Why Verana?

I am inspired by the mission to get the right medicines to patients, faster. At Verana, we have an unparalleled depth of real-world data, combined with the expert data insights and clinical expertise and supported by technology and advanced analytics, to be a partner in shifting the drug development paradigm by enabling acceleration through innovation.

Dominique Connolly, RN, NP

Vice President of Clinical Data Strategy

Dominique Connolly, RN, BSN, MA, serves on the Medical team as the Vice President of Clinical Data Strategy at Verana Health. Connolly is a Nurse Practitioner with more than 20 years of experience in healthcare and oncology, with a recent focus in optimizing approaches for data curation, as well as building and scaling teams. Prior to joining Verana Health, Connolly served at Flatiron Health as Senior Clinical Director for the Research Platforms team, as well as Director of Clinical Data Abstraction, where she built and oversaw the unstructured data processing efforts. She earned a Bachelor of Nursing degree from the University of Pennsylvania and a Master of Nursing degree from New York University.

Dominique Connolly, RN, NP on LinkedIn
Dominique Connolly, <span>RN, NP</span>

Why Verana?

Our overall goal is to help patients by getting the treatments that work to those who need them faster and more effectively.

Aracelis Torres, PhD, MPH

VP, Quantitative Sciences

Aracelis Torres, PhD, MPH is Vice President of Quantitative Sciences where she oversees the quantitative sciences team working to develop and implement rigorous methodology to generate sound scientific evidence from real-world data. Dr. Torres is an epidemiologist with over ten years of academic and industry experience. Prior to joining Verana Health, she was a Director of Quantitative Sciences at Flatiron Health, where her work focused on translation of real-world oncology data to generate evidence. While at Flatiron Health, she led efforts related to the development of real-world endpoints, novel study designs, and prospective evidence generation while also serving as the Quantitative Sciences lead for the organization’s broader research collaboration with the FDA. She is also currently an Adjunct Professor at Columbia University Graduate School of Arts and Sciences, where she teaches a course on large-scale data processing and analysis. 

Dr. Torres received a PhD in Cancer Epidemiology from Johns Hopkins Bloomberg School of Public Health, an MPH in Chronic Disease Epidemiology from Yale University’s School of Public Health, and a BS in Molecular, Cellular, and Developmental Biology from Yale University.

Aracelis Torres, PhD, MPH on LinkedIn
Aracelis Torres, <span>PhD, MPH</span>

Why Verana?

Verana’s mission to rigorously generate insights from real-world data is both inspiring and exciting. It provides a unique opportunity to tackle some of the toughest challenges in clinical research while keeping patients at the forefront of our work.

Yana Nikitina

Vice President of Engineering

Yana Nikitina is Vice President of Engineering, where she leads technology strategy and product development.

Yana brings over two decades of experience of building scalable, compliant, resilient, interoperable products. In the past years, she focused on accelerating growth in the Fintech space (LendingClub, Varo Bank and Braintree/PayPal). Yana held leadership roles in Data Platform, Actionable Insights, Mobile bank app, Payment Processing and Commerce Payment Platform.

Yana holds a BS in Computer Science from UC Davis.

 

Yana Nikitina on LinkedIn
Yana Nikitina

Why Verana?

Verana's mission strongly aligns with my personal values. I believe it will make a positive real-world impact and improve lives and I am excited to advance the application of innovative technologies to accelerate research in medicine.

Lindsey Karberg, MS

Vice President,
Marketing

Lindsey Karberg is Vice President of Marketing where she brings more than 15 years of experience leading groundbreaking marketing and digital innovation efforts for global healthcare organizations, including three successful start-ups. 

Prior to joining Verana Health, Lindsey was the Vice President of Digital Strategy & Innovation at AbbVie where she led an internal digital incubator and innovation consulting arm supporting multiple therapeutic areas. Lindsey originally came to AbbVie (formerly Allergan) through the acquisition of ZELTIQ for $2.4B, leading the consumer and physician digital marketing and digital product strategy for the CoolSculpting brand, pre- and post-acquisition. Prior to that, Lindsey built and ran global digital and marketing communications at Natera, a Silicon Valley-based genetic testing company that went public ($180M IPO) during Lindsey’s time there. Before that, she oversaw digital and consumer marketing efforts for Ultherapy and Cellfina at Ulthera, Inc. to help position the company for a $600 million acquisition by Merz Pharmaceuticals. And, her love for digital health started at Amendola Communications, where she built the agency’s social media arm and supported the marketing and public relations outreach for healthcare information technology clients such as McKesson, Allscripts, RelayHealth, Sage, and more. 

Lindsey holds a B.A. from Arizona State University and an M.S. from Boston University.

Lindsey Karberg, MS on LinkedIn
Lindsey Karberg, <span>MS</span>

Why Verana?

Data has the power to make a positive impact in healthcare. Working for a company that sits at the center of the healthcare data ecosystem is meaningful and motivating. I may not be a clinician, but working here, I, too, can play a role in changing and saving lives.

Michelle McGovern, JD, MS

General Counsel

Michelle McGovern is the General Counsel at Verana Health, where she works to find solutions that help set the market standard for data privacy in an increasingly complex legal environment.  Michelle was previously the Deputy General Counsel at Redesign Health, a venture-backed incubator that, during her tenure, raised $350M, and built, launched and scaled more than two dozen healthcare companies. Michelle also worked at Pfizer, where her roles included supporting clinical trials and pharmacovigilance, building sustainable markets for pharmaceutical products in the developing world, and serving as the North America Legal Lead for Upjohn, Pfizer’s $12B legacy products and generics business.

Michelle completed Northwestern University’s accelerated journalism degree program, graduating in four years, magna cum laude, with a Bachelor’s of Science and Master’s of Science in Journalism, and received her JD, cum laude, from Northwestern University’s Pritzker School of Law. Michelle has been credentialed by the International Association of Privacy Professionals as a Certified Information Privacy Manager. Michelle is also the President of the Board of Directors of 826NYC, a charity that helps under-resourced youth write their own paths forward, regardless of circumstance.

Michelle McGovern, JD, MS on LinkedIn
Michelle McGovern, <span>JD, MS</span>

Why Verana?

It is a privilege to work for a company that strives to improve the lives of patients, while serving as a steward of their health information. The importance of what we do, and of who we serve, inspires me to approach legal questions with both creativity and care.

Almer Mendoza, MBA

Vice President Controller

Almer brings more than 20 years of experience in corporate finance, accounting, and auditing. Prior to joining Verana Health, Almer was VP Corporate Controller at Navis LLC – a leading provider of global cargo handling software, where he managed the worldwide accounting in more than 20 countries. Prior to Navis, he was VP Finance or Corporate Controller in several public and private technology companies, where he built accounting teams, completed first audits, helped prepare for initial public filings, implemented ERPs, and integrated acquired companies. He started his career as an auditor at Ernst and Young LLP.

Almer received his MBA from Pepperdine University, and his BS in Accounting from Northwestern State University. He is a licensed Certified Public Accountant.

Almer Mendoza, MBA on LinkedIn
Almer Mendoza, <span>MBA</span>

Why Verana?

Verana’s data platform that helps accelerate healthcare innovation and drug development excites me. I have been wanting to join a Company that help people. I am motivated to contribute to the success of the Company.

Sujay Jadhav, MBA Chief Executive Officer Sujay Jadhav, MBA on LinkedIn
Marc Berger, JD, MBA Chief Operations Officer Marc Berger, JD, MBA on LinkedIn
Marie-Eve Piche, MBA, MS Chief Financial Officer Marie-Eve Piche, MBA, MS on LinkedIn
Lawrence Whittle Chief Commercial Officer Lawrence Whittle on LinkedIn
Chris Reiling, BA Chief Revenue Officer Chris Reiling, BA on LinkedIn
Shrujal Baxi, MD, MPH Senior Vice President of Clinical and Scientific Solutions Shrujal Baxi, MD, MPH on LinkedIn
Kirk Fjeldheim Senior Vice President, Engineering and Security Kirk Fjeldheim on LinkedIn
Ann Watson Senior Vice President,
People & Culture
Ann Watson on LinkedIn
Sonja Wustrack, MPH Senior Vice President,
Commercial Operations
Sonja Wustrack, MPH on LinkedIn
Dominique Connolly, RN, NP Vice President of Clinical Data Strategy Dominique Connolly, RN, NP on LinkedIn
Aracelis Torres, PhD, MPH VP, Quantitative Sciences Aracelis Torres, PhD, MPH on LinkedIn
Yana Nikitina Vice President of Engineering Yana Nikitina on LinkedIn
Lindsey Karberg, MS Vice President,
Marketing
Lindsey Karberg, MS on LinkedIn
Michelle McGovern, JD, MS General Counsel Michelle McGovern, JD, MS on LinkedIn
Almer Mendoza, MBA Vice President Controller Almer Mendoza, MBA on LinkedIn

Our Board

Close

David W. Parke II, MD
(Executive Chairman)

Chief Executive Officer

David W. Parke II, M.D.
Dr. Parke served from 2009 to 2022 as the Chief Executive Officer of the American Academy of Ophthalmology. He is now Executive Chairman of Verana Health, Inc. and remains CEO Advisor at the Academy.
After undergraduate education at Stanford University and medical school of Baylor College of Medicine, Dr. Parke completed residency training and chief residency at Baylor’s Cullen Eye Institute followed by fellowships in diseases and surgery of the retina and vitreous.
He served for 17 years as president and chief executive officer of the Dean McGee Eye Institute and Professor and Chair of the Department of Ophthalmology at the University of Oklahoma. After serving as president of the American Academy of Ophthalmology in 2008, Dr. Parke was chosen to become its full-time CEO.
He has served on the boards of companies in the insurance and digital health space. He is Past-President of the Council of Medical Specialty Societies.
Dr. Parke has been president of the Association of University Professors of Ophthalmology and director of the American Board of Ophthalmology. In 2009 he was elected to Academia Ophthalmologica Internationalis.
His most recent professional and scholarly activities have centered on health policy and economics, on biomedical organizational leadership and development, and on big data analytics.

David W. Parke II, MD<br><span>(Executive Chairman)</span>
David W. Parke II, MD
(Executive Chairman)

Chief Executive Officer,
American Academy of Ophthalmology

Brook Byers

Founding Partner,
Kleiner, Perkins, Caufield & Byers

Brendan Bulik-Sullivan
(Observer)

Partner,
GV

Eli Casdin
(Observer)

Chief Investment Officer and Founder,
Casdin Capital

Sujay Jadhav, MBA

CEO,
Verana Health

Joel Krikston, MBA
(Observer)

Managing Director,
Merck Global Health Innovation Fund

Jeffrey Low, MD, MBA

Principal,
Novo Growth

Michael T. Sheppard, CPA, CAE

Chief Executive Officer,
American Urological Association

James C. Stevens, MD, FAAN

President,
American Academy of Neurology

Julie Sunderland

Co-Founder and Managing Director,
Biomatics Capital Partners

Krishna Yeshwant, MD

Managing Partner,
GV

Asish K. Xavier, PhD, MBA

VP of Venture Investments,
Johnson & Johnson Innovation - JJDC, Inc.

Our Advisors

Close
Mark Blumenkranz, MD

Co-Founder,
Verana Health and Lagunita Biosciences

Jennifer Cook

Strategic Advisor

Theodore Leng, MD

Medical Advisor

Steven Schwartz, MD

Ahmanson Professor in Ophthalmology,
Stein Eye Institute, UCLA

Our Investors

Verana Health is backed by leading institutional investors and industry veterans:

Google Ventures
Casdin Capital
Define Ventures
Biomatics Capital
Lagunita Biosciences
Revelation Partners
Johnson & Johnson Innovation
Novo Holdings

Brook Byers, founding member and senior partner of Kleiner, Perkins, Caufield, and Byers.